Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-141290

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Sep 9, 2016
Accepted (ET)
Sep 13, 2016 · 6:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 9, 2016P100,000$19.7197A3,152,130IBy LP
Common StockF1Sep 12, 2016P22,587$19.9179A3,174,717IBy LP
Common StockF1Sep 13, 2016P16,448$20.2769A3,191,165IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses